|
Ditto,
This is old fashioned thinking from your onc. You can quote the latest trials involving Herceptin (B-31, HERA) that do show a 50% risk reduction in recurrence for early Herceptin. Your onc. should brush up on the latest info and try to be a little more forward thinking. Be firm. Being node neg. you are somewhat at a lesser risk of recurrence but it still can't hurt.
XOXO
Anne
|